Skip to main content
. 2021 Sep 23;10(2):87–91. doi: 10.1055/s-0041-1736343

Table 2. Treatment characteristics.

Characteristics ( N )%
Chemotherapy regimens in first line
FOLFOX 9 (29.03)
FOLFIRI 5 (16.13)
Cap-OX 11 (35.48)
Cap IRI 2 (6.45)
IFL 4 (12.9)
Biological agents received
Yes 14 (45.16)
No 17 (54.8)
Progression free survival (first line) 17.23 months(13.0–46.8)
Median overall survival 81.6 months(69.73–117.9)